TMFEBCapital

Todd Campbell

TMFEBCapital’s Activity

Yesterday

NL

Article

EBCapitalMarkets published an article 3:17 PM

Why Exact Sciences Corporation Is Dropping Today

Exact Sciences shares were cut to neutral today by Goldman Sachs.

NL

Article

EBCapitalMarkets published an article 2:04 PM

Why Synergy Pharmaceuticals, Inc. Is Surging Higher Today.

Speculation that Synergy Pharmaceuticals may be up for sale sent shares surging today.

NL

Article

EBCapitalMarkets published an article 1:44 PM

Why Diplomat Pharmacy Inc. Is Soaring Higher Today.

After pricing its secondary offering of shares at $29 per share, Diplomat Pharmacy, Inc. shares are climbing.

NL

Article

EBCapitalMarkets published an article 12:00 AM

Should Investors Toss in the Towel on Amarin Corp Plc?

Awash with possibilities a decade ago, Amarin ultimately fell as low as $1 per share; tune in to find out what happened.

Wed Mar 25

NL

Article

EBCapitalMarkets published an article 6:18 PM

3 Biotech Stocks That Dropped Yesterday -- Is 1 a Buy?

Esperion Therapeutics, Inc, Novavax, Inc., and Ziopharm are all seeing their shares drop sharply this week.

NL

Article

EBCapitalMarkets published an article 1:40 PM

Why Ziopharm Oncology, Inc. Shares Burst Today.

Ziopharm Oncology Inc.'s shares are retreating following a more than doubling since January.

NL

Article

EBCapitalMarkets published an article 1:16 PM

Why Esperion Therapeutics, Inc. Shares Burst Today.

After more than doubling, Esperion Therapeutics, Inc. shares are tumbling following the completion of a secondary offering yesterday.

Tue Mar 24

NL

Article

EBCapitalMarkets published an article 2:00 PM

Why Abiomed, Inc. is Soaring Higher Today

Abiomed Inc. won approval for another new cardiovascular surgery device.

NL

Article

EBCapitalMarkets published an article 1:11 PM

Why OvaScience Inc. is Sky-rocketing Higher Today

OvaScience Inc. shares are jumping on hopes that the company can revolutionize in vitro fertilization.

Mon Mar 23

Rule Breakers article.

EBCapitalMarkets published an update. 12:24 PM

NL

Article

EBCapitalMarkets published an article 12:08 PM

Why ImmunoGen, Inc. is Soaring Higher Today

Takeda Pharmaceutical has licensed ImmunoGen's antibody-drug conjugate technology.

Sat Mar 21

NL

Article

EBCapitalMarkets published an article 11:02 AM

Drug Spending Is Soaring: 3 Takeaways You Can't Miss

Drug spending in the U.S. showed solid growth in several major indications; here’s what it means to you.

Fri Mar 20

NL

Article

EBCapitalMarkets published an article 10:32 AM

Why Prothena Corporation Plc is Soaring Higher Today

Results for Prothena's early-stage Parkinson's disease drug, PRX-002, have sent shares surging.

NL

Article

EBCapitalMarkets published an article 9:54 AM

This Tiny Biotech Offers Up New Hope for Parkinson's Disease Patients

Phase 1 trial results for Prothena Corporation's PRX-002 could indicate that this drug may help treat Parkinson's disease someday.

Thu Mar 19

NL

Article

EBCapitalMarkets published an article 1:16 PM

Why Juno Therapeutics Inc is Soaring Higher Today

Juno Therapeutics Inc.'s fourth quarter earnings did little to dent investor enthusiasm for its cancer research.

NL

Article

EBCapitalMarkets published an article 12:49 PM

Why Esperion Therapeutics, Inc. is Sky-Rocketing Higher

Esperion Therapeutics, Inc. is raising money to fund development of its cholesterol lowering drug ETC-1002.

NL

Article

EBCapitalMarkets published an article 10:38 AM

In Case You Missed It, This Tiny Biotech Is Poised for Explosive Growth

Amicus Therapeutics, Inc. plans to file its drug for Fabry disease with EU and U.S. regulators soon.

Wed Mar 18

NL

Article

EBCapitalMarkets published an article 5:39 PM

Dividend Stocks: 2 to Avoid, 1 to Buy

Motley Fool contributor Todd Campbell offers up two dividend-paying healthcare stocks to avoid and one that could be a good buy for long-term income investors.

NL

Article

EBCapitalMarkets published an article 2:54 PM

Biotech Stocks: 2 to Avoid, 1 to Buy

Motley Fool contributor Todd Campbell offers insight on three biotech stocks, including two that investors should stay away from.

NL

Article

EBCapitalMarkets published an article 12:30 PM

3 Things You Need to Know About Achillion Pharmaceuticals Inc.

Achillion Pharmaceuticals has a big opportunity in hepatitis C, but it also faces some risks.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 69.61
Player Rank 22841 out of 75157
Score 197.82
Score Change Today +37.40
Accuracy 58.82%
Active Picks 34
Total Picks 34
Best Pick MDVN (+100.88)
Worst Pick KBH (-50.64)
Average Score per Pick 5.82
Charms Earned 6
Highest Rated Favorite No Favorites Selected
Go to TMFEBCapital’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFEBCapital’s 10 Latest Posts